Floatz logo

TACROLIMUS

Sleep

Stanford UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the Sleep cohort.

Asset / SponsorPhaseRating
Trazodone
Johns Hopkins University
Phase 4BB
MELATONIN
Duke University
Phase 3BB
Olanzapine
Central Institute of Psychiatry, Ranchi, India
Phase 4BB
Daridorexant
University Hospital, Montpellier
Phase 4BB
Bxcl501
Peking University First Hospital
Phase 4BB

View all 19 →

Same molecule, other indications

TACROLIMUS is also rated in:

disease related to transplantationDormant
BBB
Indicative ·
79 / 100
View asset →
disease related to solid organ transplantationDormant
BBB
Indicative ·
76 / 100
View asset →
beta-thalassemia majorDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →